In particular, gain-of-function CaSR mutations result in autosomal dominant hypocalcemia (ADH) or type 5 Bartter syndrome and eight of them are clustered in loop 2 close to the two cysteines responsible for receptor homodimerization, i.e., cys129 and cys131 [19]. Here, CASR is linked to autosomal dominant hypocalcemia.